[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"revision-hip-arthroplasty\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:revision-hip-arthroplasty":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100641087","post-market-clinical-follow-up-pmcf-study-evaluating-the-safety-and-efficacy-of-tpmed-revision-hip-prosthesis-system-100641087",false,"NCT07653295","Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System","A Multicenter, Prospective, Observational, Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System","Inclusion Criteria:\n\n* Individuals aged 18 years and older,\n* Male or female participants,\n* Participants who have undergone Revision Hip Arthroplasty (either total revision or partial component revision) for any indication (such as a documented joint failure or prosthesis-related clinical complication),\n* Participants in whose revision procedure the Tıpmed™ Revision Hip Prosthesis System components were utilized,\n* Participants who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship),\n* Participants who have voluntarily signed the written Informed Consent Form (ICF).\n\nExclusion Criteria:\n\n* Subjects currently participating in any other interventional clinical trial.","ALL","18 Years",{"count":19,"type":20},35,"ESTIMATED","OBSERVATIONAL","This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Revision Hip Prosthesis System in adult participants undergoing revision hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.",[24,25,26,27,28,29],"Revision Hip Arthroplasty","Aseptic Loosening of Prosthetic Joint","Prostheses-related Infections","Joint Instability","Periprosthetic Fractures","Prosthesis Failure",[31,24,32,33,34],"Hip Prosthesis","Revision Hip Prosthesis","Post-Market Clinical Follow-Up (PMCF)","Harris Hip Score (HHS)","RECRUITING","2026-06-17",{"date":38,"type":39},"2026-06-18","ACTUAL",{"date":41,"type":39},"2024-03-12",{"date":43,"type":20},"2029-03-31",{"name":45,"class":46},"TIPMED Medical Device Manufacturing Ltd. Co.","INDUSTRY",4,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100494721","m-vizion-macroscopic-radiographic-study-100494721","NCT05721859","M-Vizion™ Macroscopic Radiographic Study","Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study","Inclusion Criteria:\n\n* Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).\n* Ability to understand and provide written authorization for use and disclosure of personal health information.\n* Subjects who are able and willing to comply with the study protocol and follow-up visits.\n* Patients requiring a revision total hip replacement.\n* Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.\n* Male and female patients ages 21 - 80 years of age at the time of surgery.\n\nExclusion Criteria:\n\n* Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.\n* Patients with a systemic or metabolic disorder leading to progressive bone deterioration.\n* Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and\u002For fixation to the prosthesis.\n* Patients with an active or suspected latent infection in or about the hip joint.\n* Patients that are incarcerated.","21 Years","80 Years",{"count":58,"type":20},70,"Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.",[24],[62,63,64],"revision","hip","arthroplasty","2025-05-05",{"date":67,"type":39},"2025-05-08",{"date":69,"type":39},"2022-10-12",{"date":71,"type":20},"2026-06-01",{"name":73,"class":46},"Medacta USA",7,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":82,"targetDuration":84,"studyType":21,"phases":4,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":4},"100560917","cementation-of-cup-and-the-risk-of-second-revision-100560917","NCT06583382","Cementation of Cup and the Risk of Second Revision","Risk for Second Revision in Patients With Cemented Versus Non-cemented Acetabular Component at Primary THA. A National Cohort Study From DHR","Inclusion Criteria:\n\n* Primary osteoarthritis as the indication for the primary THA.\n* Has experienced a first revision with exchange of the liner, femoral head and\u002For acetabular component either with or without exchange of the femoral component.\n* Femoral with a size of 28mm, 32mm or 36mm after the first revision\n* Surgery with the posterior approach.\n\nExclusion Criteria:\n\n* Isolated revision of the femoral component.\n* Constrained liner.\n* Metal-on-metal implant.",{"count":83,"type":20},60000,"15 Years","Background:\n\nThe fixation method of the acetabular component during the primary total hip arthroplasty (THA) affects the surgical techniques implemented in the revision surgery and may influence the risk of second revision.\n\nObjectives:\n\nThe objectives of this study are to investigate the risk of second revision of the cup alone or any component after first cup revision following cemented or non-cemented cup in the primary THA.\n\nMethods\u002Fdesign:\n\nThe study is a nationwide register-based cohort study and will follow the reporting of studies Conducted using Observational Routinely collected health Data (RECORD) guidelines. We will compare the risk of undergoing a second revision between cemented and uncemented revised acetabular component by reporting the absolute risk of second revision of 1) the acetabular component and 2) any other component. The cumulative incidence of revision will be estimated using Fine-Gray regression to model the cumulative incidence function, accounting for the competing risk of death. We will apply both a crude and a multivariable adjusted model adjusting for age, sex, Charlson Comorbidity Index (CCI) and the 5-year intervals during which the primary operation was performed.",[87,24],"Total Hip Arthroplasty (THA)",[89,90,91,92,93,94,95],"Cup cementation","total hip arthroplasty","THA","Revision","Second Revision","Re-revision","cement","NOT_YET_RECRUITING","2024-09-04",{"date":99,"type":39},"2024-09-19",{"date":101,"type":20},"2024-10-01",{"date":103,"type":20},"2026-10-01",{"name":105,"class":106},"Bispebjerg Hospital","OTHER"]